Sport research · MMA

Peptides for MMA: striking, grappling and the research behind recovery

Mixed martial arts asks the body to absorb strikes, takedowns and submissions in the same round. Here is how those loads map onto published peptide research — and the anti-doping line every tested fighter needs to know.

Head-impact sportWADA 2026 status checkedVerified PubMed citations

Tested athletes: read this first

Under the WADA 2026 Prohibited List (in force from 1 January 2026), BPC-157 is named under S0, TB-500 under S2.3, Ipamorelin and Tesamorelin under S2.2.4 and MOTS-c under S4.4.1 — all prohibited in and out of competition. Research peptides with no regulatory approval anywhere are caught by S0’s catch-all wording. Tested athletes: these are banned. South African athletes can check with SAIDS and the official 2026 List.

The demands

What MMA asks of the body

MMA is three sports in one training week: striking (boxing, Muay Thai, kickboxing), wrestling for takedowns and cage control, and Brazilian jiu-jitsu for submissions. Each brings its own injury pattern — hand and shin impact from striking, knee and shoulder trauma from wrestling scrambles, elbow and knee ligament stress from joint locks — and the combination means an MMA athlete rarely has a week without something healing.

Head impact comes from punches, kicks, knees, elbows and the floor. The Professional Fighters’ Brain Health Study recruited MMA fighters alongside boxers and found that fight exposure tracked with lower regional brain volumes and slower processing speed. MMA-specific long-term outcome data are still young, which is exactly why the honest summary is "we do not know enough yet", not "the sport is safe".

South African MMA has grown quickly through EFC and regional promotions, with gyms concentrated in Johannesburg, Pretoria, Cape Town and Durban. Promotions set their own testing rules, but any athlete who crosses into a WADA-Code programme — amateur federations, national teams — is subject to the full Prohibited List.

Mapped to the evidence radar

Each demand below is mapped to one of the ten fixed research areas on our evidence radar. The heavier the weight, the more that area counts when compounds are ranked for MMA: Recovery & Repair ×3, Cognition & Focus ×3, Sleep & Recovery Rhythm ×2, Muscle & Body Composition ×1, Gut & Immune ×1.

Ligament and joint trauma · Recovery & Repair
Knee (ACL/MCL), shoulder and elbow ligaments take the brunt of grappling. The repair peptides with the largest literature, BPC-157 and TB-500, are studied in rodent tendon, ligament and muscle models; human evidence is limited.
Strikes and ground impact · Cognition & Focus
Brain-health research relevant to fighters is observational (imaging and cognition vs fight exposure). Neurotrophic peptide trials come from stroke and hospital TBI populations; the dedicated research page covers them, including the neutral results.
Weight cut and camp fatigue · Sleep & Recovery Rhythm
Fighters often cut weight in the final week, which disrupts sleep and recovery. Sleep-rhythm evidence in this catalogue comes from Russian gerontology research in older adults.
Mat-borne infections and gut stress · Gut & Immune
Skin infections (ringworm, staph) are a known grappling hazard, and hard training plus weight cuts stress the gut. Gut and immune research here is mostly animal (KPV, BPC-157) plus small human glutathione trials.

By the evidence

Highest-scoring compounds for MMA

Ranked by weighted evidence score across MMA’s research areas. A reading aid for the literature — not a recommendation, and not a performance claim.

Top three for MMA, overlaid · strength of published evidence per area

Show the scores as a table

Evidence score per research area, 0 to 10
Area	KLOW	Cerebrolysin	Semax
Fat Loss & Metabolism	2	1	2
Appetite Control	1	1	1
Muscle & Body Composition	6	2	3
Recovery & Repair	10	8	7
Skin, Hair & Glow	10	3	3
Gut & Immune	10	4	4
Cognition & Focus	6	10	10
Mood & Calm	5	6	7
Sleep & Recovery Rhythm	3	5	5
Longevity & Energy	9	6	6

KLOW

In stock

7.0MMA match

Recovery & RepairPrimary10/10

Extensive animal and tissue studies demonstrate rapid healing of tendon, ligament, muscle, and bone.

Cognition & Focus6/10

Copper chaperoning supports neurovascular integrity and dampens neuroinflammatory cascades.

Sleep & Recovery Rhythm3/10

Indirect — studied via anti-inflammatory and nervous-system gene-expression pathways; limited direct sleep data.

S0 + S2.3KLOW contains BPC-157 (named in S0) and TB-500 (named in S2.3). Tested athletes: this is banned.

Research overview View compound

Cerebrolysin

Restocking

7.0MMA match

Recovery & RepairPrimary8/10

Robust stroke and traumatic brain injury rehabilitation trials prove functional neuroplastic recovery.

Cognition & Focus10/10

Extensive randomized trials in vascular dementia and Alzheimer’s document clear cognitive protection.

Sleep & Recovery Rhythm5/10

Small studies report EEG normalisation in dementia; sleep-specific data are limited.

M2.2Not named, and approved as a medicine in a number of countries. Its trials use intravenous infusions; outside hospital care, IV infusions over 100 mL per 12 hours are a prohibited method (M2.2).

Research overview Notify me on restock Glossary

Semax

Restocking

6.8MMA match

Recovery & RepairPrimary7/10

Demonstrates robust neuro-rehabilitation and cerebral ischemic protection in clinical cohorts.

Cognition & Focus10/10

Registered medicine with extensive clinical trials proving rapid BDNF induction, memory, and stroke recovery.

Sleep & Recovery Rhythm5/10

Enhances daytime cognitive efficiency, promoting stabilized circadian sleep-wake balance.

S0 (contested)Not named. Semax is a registered medicine in Russia, so S0’s approval test is contested, and it is an ACTH(4-10) analogue (S2.2.2 covers corticotrophins). No published ruling — tested athletes should treat it as a risk and ask first.

Research overview Notify me on restock Glossary

Tesamorelin

Restocking

6.4MMA match

Recovery & RepairPrimary6/10

Raises IGF-1, the axis studied for collagen synthesis and connective-tissue repair.

Cognition & Focus7/10

Randomized controlled trials confirm significant executive cognitive function gains in older adults.

Sleep & Recovery Rhythm7/10

GHRH signaling deepens Stage 4 slow-wave restorative sleep architecture.

S2.2.4Tesamorelin is named as a GHRH analogue (S2.2.4), non-Specified, prohibited at all times — even though it is an approved medicine elsewhere. Tested athletes: this is banned.

Research overview Notify me on restock Glossary

BPC-157

In stock

6.2MMA match

Recovery & RepairPrimary9/10

Extensive animal and tissue studies demonstrate rapid healing of tendon, ligament, muscle, and bone.

Cognition & Focus5/10

Modulates the gut-brain axis and exhibits dopaminergic and serotonergic neuroprotective effects.

Sleep & Recovery Rhythm3/10

Indirect — studied via gut-brain and dopaminergic/serotonergic modulation in rodents; limited direct sleep data.

S0BPC-157 is named by the 2026 List as an example of a non-approved substance (S0), prohibited in and out of competition. Tested athletes: this is banned.

Research overview View compound Glossary

Selank

Restocking

6.1MMA match

Recovery & RepairPrimary5/10

Buffers systemic allostatic stress load, accelerating psychological and physiological recovery.

Cognition & Focus8/10

Prevents stress-induced cognitive decline and boosts working memory and mental resilience under pressure.

Sleep & Recovery Rhythm7/10

Resolves anxiety-driven insomnia, restoring natural nocturnal melatonin and sleep continuity.

S0 (contested)Not named. Selank is registered in Russia, which arguably takes it outside S0’s "no approval anywhere" wording — but anti-doping bodies do not publish a ruling on it. Tested athletes should treat it as a risk and ask their national anti-doping organisation first.

Research overview Notify me on restock Glossary

Scores (0–10) rate the strength of the published research link in each area — large human trials score highest, then smaller human studies (Russian clinical research counted at full weight), then animal and lab work. They describe the literature, not an outcome for any person or athlete. All compounds are supplied strictly for laboratory research purposes and are not for human consumption.

The literature

What published research says about MMA

Active professional MMA fighters and boxers: more fights and more years fighting were associated with smaller thalamic volumes and slower processing speed.[1]
International concussion-in-sport consensus (Amsterdam 2022): recognise, remove, and return to training only through a graded protocol.[2]

Brain health

Head impact, concussion and the neuro research

MMA involves repeated head impact, so brain-health research is part of the honest picture. Two evidence reviews on this site cover it without the marketing: neuropeptides and brain injury (concussion, traumatic brain injury and CTE — including the trials that found no benefit) and Cerebrolysin and stroke.

The short version: no peptide has been shown to prevent or treat sport-related brain injury, and there is no proven treatment for chronic traumatic encephalopathy. Anyone with concussion symptoms should be removed from play and assessed by a doctor, and return to sport should follow a graded protocol.

Anti-doping

WADA 2026 status of every compound on this page

Quoted from the WADA Prohibited List 2026 (in force 1 January 2026). Where a compound is not named, we say so and explain how the List’s wording applies.

WADA 2026 Prohibited List status per compound
Compound	Status	What the 2026 List says
KLOW	Prohibited — named · S0 + S2.3	KLOW contains BPC-157 (named in S0) and TB-500 (named in S2.3). Tested athletes: this is banned.
Cerebrolysin	Method limit (IV) · M2.2	Not named, and approved as a medicine in a number of countries. Its trials use intravenous infusions; outside hospital care, IV infusions over 100 mL per 12 hours are a prohibited method (M2.2).
Semax	Treat as prohibited · S0 (contested)	Not named. Semax is a registered medicine in Russia, so S0’s approval test is contested, and it is an ACTH(4-10) analogue (S2.2.2 covers corticotrophins). No published ruling — tested athletes should treat it as a risk and ask first.
Tesamorelin	Prohibited — named · S2.2.4	Tesamorelin is named as a GHRH analogue (S2.2.4), non-Specified, prohibited at all times — even though it is an approved medicine elsewhere. Tested athletes: this is banned.
BPC-157	Prohibited — named · S0	BPC-157 is named by the 2026 List as an example of a non-approved substance (S0), prohibited in and out of competition. Tested athletes: this is banned.
Selank	Treat as prohibited · S0 (contested)	Not named. Selank is registered in Russia, which arguably takes it outside S0’s "no approval anywhere" wording — but anti-doping bodies do not publish a ruling on it. Tested athletes should treat it as a risk and ask their national anti-doping organisation first.

FAQ

MMA: common questions

Can MMA fighters use BPC-157 or TB-500?

Not in any tested programme. BPC-157 is named under S0 and TB-500 under S2.3 of the 2026 WADA Prohibited List, both prohibited in and out of competition. Promotions with their own testing commonly adopt the WADA List.

Why does the ranking weight gut and immune for MMA?

Grappling on shared mats raises skin-infection risk and weight cuts stress digestion, so Gut & Immune is a real demand of the sport. It carries a low weight; Repair and Cognition carry the most.

Is there research on peptides and CTE in fighters?

No trial has tested any peptide in fighters for CTE, and there is no proven treatment for CTE. Our brain-injury research page reviews the neuropeptide literature honestly, including where it was negative.

Keep reading